HER2 prognostic values in non-muscle-invasive bladder cancer: a step towards personalized treatment for BCG instillation
Abstract This comment discusses the findings of a study on the prognostic significance of HER2 expression in high-risk non-muscle-invasive bladder cancer (NMIBC) patients treated with Bacillus Calmette-Guérin (BCG) therapy. The study highlights that high HER2 expression is an independent predictor o...
Saved in:
| Main Authors: | Xinpei Deng, Runhao Zheng, Xingliang Tan, Kai Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Online Access: | https://doi.org/10.1007/s12672-025-02751-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
by: Dong Gyun Kim, et al.
Published: (2023-03-01) -
Development and validation of clinical prediction model for post-treatment recurrence in high-risk non-muscle invasive bladder cancer after BCG intravesical instillation
by: WANG Haitao, et al.
Published: (2025-05-01) -
Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01) -
Nogapendekin alfa Inbakicept-pmln (Anktiva) with BCG: A Promising Arsenal in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Intervention
by: ArunSundar MohanaSundaram, et al.
Published: (2025-04-01) -
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
by: Jong Ho Park, et al.
Published: (2024-11-01)